Companies in the oncology sector developing innovative solutions and technologies.
Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.
Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.
Hexagon Bio discovers and develops new cancer therapies using microbial natural products, genomic data, and artificial intelligence.
Pathos applies artificial intelligence, patient data analysis, and biological modeling to drug discovery and clinical development.
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
ZAP Surgical Systems is a medical company that designs and manufactures a radiosurgery platform for treating brain tumors.
Big Picture Bio is a developer of an AI-driven platform designed to identify, design, and optimize cancer combination therapies.
Connexus Therapeutics is a private, venture-backed biotechnology startup.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.
Thyme Care provides value-based oncology management services designed to coordinate care for individuals diagnosed with cancer.
Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Leo Cancer Care develops radiation therapy technologies that support cancer treatment in an upright patient position.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.
Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked